Financial Side - investment valuationsDon't forget, valuation of Singular Genomics have dropped into the $3-$4 per share range.
If we sold - great - we don't have to play that roller coaster valuation game anymore.
If we kept the shares, it will be affecting our numbers. Not ideal but it's part of the game while they have the investment ownership. Hope there are other positive investment outcomes that will reduce the weight of the Singular Gemomics negative effect.